Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: Primary 6-month results of the SAVE Study

Nguyen Q.D., Ibrahim M.A., Watters A., Bittencourt M., Yohannan J., Sepah Y.J., Dunn J.P., Naor J., Shams N., Shaikh O., Leder H.A., Do D.V.

2013
Journal of Ophthalmic Inflammation and Infection

View publication

Therapeutic Area

Back of the eye (BOTE)
Categories

Clinical development

Affiliations

Wilmer Eye Institute, Johns Hopkins University School of Medicine, 600 North Wolfe Street Maumenee 745, Baltimore, MD, United States; Santen Pharmaceuticals, Inc, Emeryville, CA, United States; Santen Pharmaceuticals, Osaka, Japan; Stanley M. Truhlsen Eye Institute, University of Nebraska Medical Center, 3902 Leavenworth Street, Omaha, NE, United States

Related Publications

Cost-Effectiveness Analysis of Low-Dose Atropine Eye Drops (0.01%) for the Treatment of Myopia in Children: A United Kingdom Perspective

Shi-van Wielink K., Dahlmann-Noor A., Li J., de Milliano T.W.L., Ernst F., Croci F., Sharma Y., Punekar Y.

Two-year prospective natural history study of EYS-associated retinitis pigmentosa using adaptive optics: the KEYS study

Masakazu H., Akiko M., Midori Y., Elena G.-S., Shohei K., Satoshi Y., Yuki T., Masanao T., Shuhei K., Yasuhiko H., Yasuo K., Kiyoko G.

Prospective natural history and clinical biomarkers of EYS-associated retinopathy in the KEYS study

Taniguchi M, Togashi Y, Yokota S, Hiraoka M, Kitahata S, Nakamura N, Yamamoto M, Mandai M, Gocho K, Toshimori M, Hirami Y, Gomi F, Kurimoto Y, Maeda A.

View all Back of the eye (BOTE) publications